TELO – telomir pharmaceuticals, inc. (US:NASDAQ)
Stock Stats
News
Telomir Pharmaceuticals (NASDAQ:TELO) is now covered by analysts at Rodman & Renshaw. They set a "buy" rating on the stock.
Telomir Pharmaceuticals Announces Telomir-1 Significantly Reduced Tumor Growth and Metastases in Aggressive Triple-Negative Breast Cancer Animal Models [Yahoo! Finance]
Telomir Pharmaceuticals Reports Telomir-1 Outperforms FDA-Approved Gold-Standard Iron Chelator Deferoxamine (DFO) in Reducing Intracellular Iron in a Human Cell Line [Yahoo! Finance]
Telomir Pharmaceuticals (NASDAQ:TELO) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
Form 8-K Telomir Pharmaceuticals, For: Jan 08
Form 8-K Telomir Pharmaceuticals, For: Jan 05
Form 8-K Telomir Pharmaceuticals, For: Dec 17
Form 8-K Telomir Pharmaceuticals, For: Dec 17
Form PRER14A Telomir Pharmaceuticals,
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.